热门资讯> 正文
SELLAS Life Sciences Group申请2亿美元混合货架
2024-03-29 04:54
- SELLAS Life Sciences Group (NASDAQ:SLS) on Thursday filed a prospectus for a mixed securities shelf offering of up to $200M.
- This prospectus is not an offer to sell these securities.
- Press Release
More on SELLAS Life Sciences
- SELLAS Life Sciences looks to raise $20M in a direct offering
- Sellas Life Sciences gains on securing orphan drug status for r/r PTCL treatment
- Seeking Alpha’s Quant Rating on SELLAS Life Sciences
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。